Posts From King World News

Mylan not relying on acquisitions if Perrigo bid fails: chairman

By Steven Scheer TEL AVIV (Reuters) – Mylan will likely win its bid to take over Irish-based generic drugmaker Perrigo Co, but if the bid fails the company can live without seeking an alternative acquisition, its chairman said on Wednesday. Mylan made an offer for Perrigo in April, which was rejected, and went hostile in September with its $25 billion all-share offer. Perrigo shareholders have until Nov. 13 to accept.

Amy Winehouse Documentary Depicts Addiction's Perfect Storm

I watched Amy, the Amy Winehouse documentary, yesterday. What an unbelievable spirit she was. What a beautiful and unique presence! The film’s depiction of the unfolding tragedy of her addiction haunted me through last night’s quasi-sleep. There was a moment in the doc where Amy has just won the Grammy Award for Best Song for “Rehab.”…

Amy Winehouse Documentary Depicts Addiction's Perfect Storm

I watched Amy, the Amy Winehouse documentary, yesterday. What an unbelievable spirit she was. What a beautiful and unique presence! The film’s depiction of the unfolding tragedy of her addiction haunted me through last night’s quasi-sleep. There was a moment in the doc where Amy has just won the Grammy Award for Best Song for “Rehab.”…

‘July phenomenon’ may not mean worse outcomes for surgeries

By Lisa Rapaport (Reuters Health) – The annual arrival each summer of a fresh crop of surgical residents and interns is not necessarily linked to worse outcomes for patients, a U.S. study suggests. Sometimes called the “July phenomenon,” this period has long been thought to be a time of year when patients might not fare as well due to the influx of less experienced clinicians, the study authors note in

‘July phenomenon’ may not mean worse outcomes for surgeries

By Lisa Rapaport (Reuters Health) – The annual arrival each summer of a fresh crop of surgical residents and interns is not necessarily linked to worse outcomes for patients, a U.S. study suggests. Sometimes called the “July phenomenon,” this period has long been thought to be a time of year when patients might not fare as well due to the influx of less experienced clinicians, the study authors note in

British cancer drugs fund changes tack: again

A British cancer drugs scheme, slammed as “stupid” by Roche’s chief executive two months ago, has undergone another about-turn, with some medicines dropped from coverage now being reinstated. The Cancer Drugs Fund (CDF), which helps patients receive cancer drugs not routinely paid for by the National Health Service (NHS), said on Wednesday that some drugs would remain available after further price negotiations with manufacturers. “It’s great news that some drugs

British cancer drugs fund changes tack: again

A British cancer drugs scheme, slammed as “stupid” by Roche’s chief executive two months ago, has undergone another about-turn, with some medicines dropped from coverage now being reinstated. The Cancer Drugs Fund (CDF), which helps patients receive cancer drugs not routinely paid for by the National Health Service (NHS), said on Wednesday that some drugs would remain available after further price negotiations with manufacturers. “It’s great news that some drugs